1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders

Details for Australian Patent Application No. 2010246609 (hide)

Owner Addex Pharma S.A. Janssen Pharmaceuticals, Inc.

Inventors Cid-Nunez, Jose Maria; Oehlrlch, Daniel; Trabanco-Suarez, Andres Avelino; Tresadern, Gary John; Vega Ramiro, Juan Antonio; Macdonald, Gregor James

Agent FB Rice

Pub. Number AU-A-2010246609

PCT Pub. Number WO2010/130424

Priority 09160059.3 12.05.09 EP

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/130424 Priority application(s): WO2010/130424

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246613-Oil-in-water emulsion of mometasone and propylene glycol

2010246608-7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors